In this week’s Video Forum, Chip Davis, president and chief executive officer of the Healthcare Distribution Alliance, provides an update on implementation of the Drug Supply Chain Security Act and how it will impact retail pharmacy operators. In addition, he addresses medication shortages, potential tariffs on pharmaceuticals, and why drug importation is still a bad idea.
Video Forum: Chip Davis, Healthcare Distribution Alliance
Strengthening the Pharmaceutical Supply Chain.
Latest
Nine of the largest pharma companies ink deals with Trump to lower drug prices
The agreements reduce prices on drugs that treat numerous costly and chronic conditions.
Merck and U.S. government partner to expand access to medicines and reduce costs for Americans
The company has committed more than $70 billion in U.S. investments to boost domestic production and innovation.
Google Trends looks at 2026 wellness shifts
Google Trends analysis revealed that new types of health-related searches emerged in the second half of 2025 and will continue into next year.
CRN appoints 2026 board leaders amid supplement regulation pressure
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.